| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.0099 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |